{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:41:42Z","timestamp":1774716102146,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T00:00:00Z","timestamp":1603497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T00:00:00Z","timestamp":1603497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["W1230416"],"award-info":[{"award-number":["W1230416"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11102-020-01099-z","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T03:31:51Z","timestamp":1603510311000},"page":"216-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0257-5524","authenticated-orcid":false,"given":"Isabela Peixoto","family":"Biscotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ria Aparecida","family":"Costa Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Loch","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berenice Bilharinho","family":"Mendonca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo Jorge Prado","family":"Arnhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Aparecido","family":"Bortolotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciani Renata Silveira","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,24]]},"reference":[{"key":"1099_CR1","volume-title":"Handbook of growth and growth monitoring in health and disease","author":"MH Aguiar-Oliveira","year":"2011","unstructured":"Aguiar-Oliveira MH (2011) Lifetime growth hormone (GH) deficiency: impact on growth, metabolism, body composition and survival capacity. In: Salvatori R (ed) Handbook of growth and growth monitoring in health and disease. Springer, New York"},{"key":"1099_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1210\/er.2009-0008","volume":"30","author":"D Kelberman","year":"2009","unstructured":"Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT (2009) Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 30:790\u2013829","journal-title":"Endocr Rev"},{"key":"1099_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1210\/edrv-16-1-63","volume":"16","author":"H de Boer","year":"1995","unstructured":"de Boer H, Blok GJ, Van der Veen EA (1995) Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63\u201386","journal-title":"Endocr Rev"},{"key":"1099_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2265.1992.tb02347.x","volume":"37","author":"RC Cuneo","year":"1992","unstructured":"Cuneo RC, Salomon F, McGauley GA, S\u00f6nksen PH (1992) The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf) 37:387\u2013397","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1099_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1530\/EJE-06-0699","volume":"156","author":"AA van der Klaauw","year":"2007","unstructured":"van der Klaauw AA, Biermasz NR, Feskens EJ, Bos MB, Smit JW, Roelfsema F et al (2007) The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH. Eur J Endocrinol 156:455\u2013462","journal-title":"Eur J Endocrinol"},{"key":"1099_CR6","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1210\/jc.2003-030840","volume":"89","author":"P Maison","year":"2004","unstructured":"Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P et al (2004) Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trails. J Clin Endocrinol Metab 89:2192\u20132199","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/17446651.2019.1689119","volume":"14","author":"KCJ Yuen","year":"2019","unstructured":"Yuen KCJ, Llahana S, Miller BS (2019) Adult growth hormone deficiency: clinical advances and approaches to improve adherence. Expert Rev Endocrinol Metab 14:419\u2013436","journal-title":"Expert Rev Endocrinol Metab"},{"key":"1099_CR8","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","volume":"321","author":"F Salomon","year":"1989","unstructured":"Salomon F, Cuneo RC, Hesp R, S\u00f6nksen PH (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797\u20131803","journal-title":"N Engl J Med"},{"key":"1099_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1530\/EJE-12-1083","volume":"168","author":"M Elbornsson","year":"2013","unstructured":"Elbornsson M, G\u00f6therstr\u00f6m G, Bos\u00e6us I, Bengtsson B, Johannsson G, Svensson J (2013) Fifteen years of GH replacement improves body composition and cardiovascular risk factors. Eur J Endocrinol 168:745\u2013753","journal-title":"Eur J Endocrinol"},{"key":"1099_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1365-2265.2002.01514.x","volume":"56","author":"JC Smith","year":"2002","unstructured":"Smith JC, Evans LM, Wilkinson I, Goodfellow J, Cockcroft JR, Scanlon MF et al (2002) Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study. Clin Endocrinol (Oxf) 56:493\u2013501","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1099_CR11","doi-asserted-by":"publisher","first-page":"E1938","DOI":"10.1210\/jc.2012-2432","volume":"97","author":"T Zueger","year":"2012","unstructured":"Zueger T, Kirchner P, Herren C, Fischli S, Zwahlen M, Christ E et al (2012) Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma. J Clin Endocrinol Metab 97:E1938\u2013E1942","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1210\/jc.2017-01542","volume":"103","author":"KCJ Yuen","year":"2018","unstructured":"Yuen KCJ, Mattsson AF, Burman P, Erfurth EM, Camacho-Hubner C, Fox JL et al (2018) Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on growth hormone replacement. J Clin Endocrinol Metab 103:768\u2013777","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR13","first-page":"3897","volume":"83","author":"B B\u00fclow","year":"1998","unstructured":"B\u00fclow B, Attewell R, Hagmar L, Malmstr\u00f6m P, Nordstr\u00f6m CH, Erfurth EM (1998) Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab 83:3897\u20133904","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR14","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1210\/jc.2012-4059","volume":"98","author":"P Burman","year":"2013","unstructured":"Burman P, Mattsson AF, Johannsson G, H\u00f6ybye C, Holmer H, Dahlqvist P et al (2013) Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J Clin Endocrinol Metab 98:1466\u20131475","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11936-016-0468-4","volume":"18","author":"SS Mahmood","year":"2016","unstructured":"Mahmood SS, Nohria A (2016) Cardiovascular complications of cranial and neck radiation. Curr Treat Options Cardiovasc Med 18:45","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"1099_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1055\/s-0043-124668","volume":"126","author":"A Amado","year":"2018","unstructured":"Amado A, Ara\u00fajo F, Carvalho D (2018) Cardiovascular risk factors in acromegaly: what\u2019s the impact of disease control? Exp Clin Endocrinol Diabetes 126:505","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1099_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/cen.13521","volume":"88","author":"G Aranda","year":"2018","unstructured":"Aranda G, Fernandez-Ruiz R, Palomo M, Romo M, Mora M, Halperin I et al (2018) Translational evidence of prothrombotic and inflammatory endothelial damage in Cushing syndrome after remission. Clin Endocrinol (Oxf) 88:415\u2013424","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1099_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12020-016-1047-x","volume":"54","author":"U Feldt-Rasmussen","year":"2016","unstructured":"Feldt-Rasmussen U, Klose M (2016) Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients. Endocrine 54:15\u201323","journal-title":"Endocrine"},{"key":"1099_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257\u2013265","journal-title":"J Am Coll Cardiol"},{"key":"1099_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1161\/01.HYP.26.3.485","volume":"26","author":"R Asmar","year":"1995","unstructured":"Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM et al (1995) Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 26:485\u2013490","journal-title":"Hypertension"},{"key":"1099_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.atherosclerosis.2015.05.007","volume":"241","author":"C Vlachopoulos","year":"2015","unstructured":"Vlachopoulos C, Xaplanteris P, Aboyans V, Brodmann M, Cifkova R, Cosentino F et al (2015) The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis 241:507\u2013532","journal-title":"Atherosclerosis"},{"key":"1099_CR22","first-page":"229","volume":"59","author":"EG Silva","year":"2003","unstructured":"Silva EG, Slhessarenko N, Arnhold IJ, Batista MC, Estefan V, Osorio MG et al (2003) GH values after clonidine stimulation measured by immunofluorometric assay in normal prepubertal children and GH-deficient patients. Horm Res 59:229\u2013233","journal-title":"Horm Res"},{"key":"1099_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1530\/eje.1.01829","volume":"152","author":"PE Clayton","year":"2005","unstructured":"Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M (2005) Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 152:165\u2013170","journal-title":"Eur J Endocrinol"},{"key":"1099_CR24","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R et al (2016) Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:3888\u20133921","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR25","unstructured":"Malachias MVB, P\u00f3voa RMS, Nogueira AR, Souza D, Costa LS, Magalh\u00e3es ME (2016) 7th Brazilian guideline of arterial hypertension: chapter 3\u2014clinical and complementary assessment. Arq Bras Cardiol 107(Suppl 3): 14\u20137"},{"key":"1099_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell M, Gunn P, Gibson S (2012) Waist-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 13:275\u2013286","journal-title":"Obes Rev"},{"key":"1099_CR27","unstructured":"Malachias MVB, Bortolotto LA, Drager LF, Borelli FAO, Lotaif LAD, Martins LC (2016) 7th Brazilian guideline of arterial hypertension: chapter 12\u2014secondary arterial hypertension. Arq Bras Cardiol 107(Suppl 3), 67\u201374"},{"key":"1099_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4236\/ojra.2019.93009","volume":"9","author":"RG Misse","year":"2019","unstructured":"Misse RG, Borges IBP, Costa-Hong VA, Bortolotto LA, Shinjo SK (2019) Functional and structural arterial vessel features of female patient with stable dermatomyositis and antisynthetase syndrome. Open J Rheumatol Autoimune Dis 9:101\u2013110","journal-title":"Open J Rheumatol Autoimune Dis"},{"key":"1099_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/jch.13129","volume":"20","author":"HCS Muela","year":"2018","unstructured":"Muela HCS, Costa-Hong VA, Yassuda MS, Moraes NC, Mem\u00f3ria CM, Machado MF et al (2018) Higher arterial stiffness is associated with lower cognitive performance in patients with hypertension. J Clin Hypertens (Greenwich) 20:22\u201330","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1099_CR30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0008-6363(01)00473-4","volume":"53","author":"MA Sader","year":"2002","unstructured":"Sader MA, Celermajer DS (2002) Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res 53:597\u2013604","journal-title":"Cardiovasc Res"},{"key":"1099_CR31","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1161\/01.CIR.92.12.3431","volume":"92","author":"M Hashimoto","year":"1995","unstructured":"Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K et al (1995) Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 92:3431\u20133435","journal-title":"Circulation"},{"key":"1099_CR32","doi-asserted-by":"publisher","first-page":"e7038","DOI":"10.1371\/journal.pone.0007038","volume":"4","author":"TL Kelly","year":"2009","unstructured":"Kelly TL, Wilson KE, Heymsfield SB (2009) Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS ONE 4:e7038","journal-title":"PLoS ONE"},{"key":"1099_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","volume":"147","author":"RN Baumgartner","year":"1998","unstructured":"Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755\u2013763","journal-title":"Am J Epidemiol"},{"key":"1099_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00198-005-1900-x","volume":"17","author":"MC Walsh","year":"2006","unstructured":"Walsh MC, Hunter GR, Livingstone MB (2006) Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int 17:61\u201367","journal-title":"Osteoporos Int"},{"key":"1099_CR35","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1210\/jc.2003-031601","volume":"89","author":"J Svensson","year":"2004","unstructured":"Svensson J, Bengtsson BA, Ros\u00e9n T, Od\u00e9n A, Johannsson G (2004) Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J Clin Endocrinol Metab 89:3306\u20133312","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1210\/jc.2013-2394","volume":"99","author":"C Gazzaruso","year":"2014","unstructured":"Gazzaruso C, Gola M, Karamouzis I, Giubbini R, Giustina A (2014) Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH\u2013an update. J Clin Endocrinol Metab 99:18\u201329","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1046\/j.1365-2265.2002.01663.x","volume":"57","author":"M Leonsson","year":"2002","unstructured":"Leonsson M, Hulthe J, Oscarsson J, Johannsson G, Wendelhag I, Wikstrand J et al (2002) Intima-media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors. Clin Endocrinol (Oxf) 57:751\u2013759","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1099_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1530\/eje.0.1360157","volume":"136","author":"V Markussis","year":"1997","unstructured":"Markussis V, Beshyah SA, Fisher C, Parker KH, Nicolaides AN, Johnston DG (1997) Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults. Eur J Endocrinol 136:157\u2013164","journal-title":"Eur J Endocrinol"},{"key":"1099_CR39","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1161\/01.CIR.103.4.520","volume":"103","author":"B Capaldo","year":"2001","unstructured":"Capaldo B, Guardasole V, Pardo F, Matarazzo M, Di Rella F, Numis F et al (2001) Abnormal vascular reactivity in growth hormone deficiency. Circulation 103:520\u2013524","journal-title":"Circulation"},{"key":"1099_CR40","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/01.ATV.16.2.310","volume":"16","author":"C Bonithon-Kopp","year":"1996","unstructured":"Bonithon-Kopp C, Touboul PJ, Berr C, Leroux C, Mainard F, Courbon D et al (1996) Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol 16:310\u2013316","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1099_CR41","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1152\/ajpheart.412.2008","volume":"295","author":"A Csiszar","year":"2008","unstructured":"Csiszar A, Labinskyy N, Perez V, Recchia FA, Podlutsky A, Mukhopadhyay P et al (2008) Endothelial function and vascular oxidative stress in long-lived GH\/IGF-deficient Ames dwarf mice. Am J Physiol Heart Circ Physiol 295:1882\u20131894","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1099_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","volume":"133","author":"G Sesmilo","year":"2000","unstructured":"Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N et al (2000) Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 133:111\u2013122","journal-title":"Ann Intern Med"},{"key":"1099_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1530\/EJE-08-0179","volume":"159","author":"AA van der Klaauw","year":"2008","unstructured":"van der Klaauw AA, Pereira AM, Rabelink TJ, Corssmit EP, Zonneveld AJ, Pijl H et al (2008) Recombinant human GH replacement increases CD34+ cells and improves endothelial function in adults with GH deficiency. Eur J Endocrinol 159:105\u2013111","journal-title":"Eur J Endocrinol"},{"key":"1099_CR44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1530\/eje.0.1420254","volume":"142","author":"LM Evans","year":"2000","unstructured":"Evans LM, Davies JS, Anderson RA, Ellis GR, Jackson SK, Lewis MJ et al (2000) The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol 142:254\u2013262","journal-title":"Eur J Endocrinol"},{"key":"1099_CR45","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/ki.1994.78","volume":"45","author":"H Tsukahara","year":"1994","unstructured":"Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS (1994) Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 45:598\u2013604","journal-title":"Kidney Int"},{"key":"1099_CR46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2265.2005.02245.x","volume":"62","author":"RW McCallum","year":"2005","unstructured":"McCallum RW, Sainsbury CA, Spiers A, Dominiczak AF, Petrie JR, Sattar N et al (2005) Growth hormone replacement reduces C-reactive protein and large-artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency. Clin Endocrinol (Oxf) 62:473\u2013479","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1099_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1530\/EC-15-0118","volume":"5","author":"UM Costa","year":"2016","unstructured":"Costa UM, Oliveira CR, Salvatori R, Barreto-Filho JA, Campos VC, Oliveira FT et al (2016) Brazilian adult individuals with untreated isolated GH deficiency do not have accelerated subclinical atherosclerosis. Endocr Connect 5:41\u201346","journal-title":"Endocr Connect"},{"key":"1099_CR48","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1210\/jc.2009-1879","volume":"95","author":"MH Aguiar-Oliveira","year":"2010","unstructured":"Aguiar-Oliveira MH, Oliveira FT, Pereira RM, Oliveira CR, Blackford A, Valenca EH et al (2010) Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J Clin Endocrinol Metab 95:714\u2013721","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR49","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1210\/jc.2007-1636","volume":"92","author":"JL Oliveira","year":"2007","unstructured":"Oliveira JL, Aguiar-Oliveira MH, D\u2019Oliveira A, Pereira RM, Oliveira CR, Farias CT et al (2007) Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults. J Clin Endocrinol Metab 92:4664\u20134670","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR50","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1530\/EJE-12-0062","volume":"166","author":"VP Araujo","year":"2012","unstructured":"Araujo VP, Aguiar-Oliveira MH, Oliveira JL, Rocha HM, Oliveira CR, Rodrigues TM et al (2012) Arrest of atherosclerosis progression after interruption of GH replacement in adults with congenital isolated GH deficiency. Eur J Endocrinol 166:977\u2013982","journal-title":"Eur J Endocrinol"},{"key":"1099_CR51","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1210\/jc.2002-020480","volume":"87","author":"DM Cook","year":"2002","unstructured":"Cook DM, Biller BM, Vance ML, Hoffman AR, Phillips LS, Ford KM et al (2002) The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adults. J Clin Endocrinol Metab 87:4508\u20134514","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR52","first-page":"1021","volume":"35","author":"G Lombardi","year":"2012","unstructured":"Lombardi G, Di Somma C, Grasso LF, Savanelli MC, Colao A, Pivonello R (2012) The cardiovascular system in growth hormone excess and growth hormone deficiency. J Endocrinol Investig 35:1021\u20131029","journal-title":"J Endocrinol Investig"},{"key":"1099_CR53","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/clc.22934","volume":"41","author":"ICL van den Munckhof","year":"2018","unstructured":"van den Munckhof ICL, Jones H, Hopman MTE, de Graaf J, Nyakayiru J, van Dijk B et al (2018) Relation between age and carotid artery intima-medial thickness: a systematic review. Clin Cardiol 41:698\u2013704","journal-title":"Clin Cardiol"},{"key":"1099_CR54","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1210\/jc.2005-2571","volume":"91","author":"JL Menezes Oliveira","year":"2006","unstructured":"Menezes Oliveira JL, Marques-Santos C, Barreto-Filho JA, Ximenes Filho R, de Oliveira Britto AV, Oliveira Souza AH et al (2006) Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation. J Clin Endocrinol Metab 91:2093\u20132099","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1210\/jc.2003-030967","volume":"89","author":"GA Laughlin","year":"2004","unstructured":"Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D (2004) The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 89:114\u2013120","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR56","doi-asserted-by":"publisher","first-page":"642","DOI":"10.7326\/0003-4819-139-8-200310210-00007","volume":"139","author":"RS Vasan","year":"2003","unstructured":"Vasan RS, Sullivan LM, D\u2019Agostino RB, Roubenoff R, Harris T, Sawyer DB et al (2003) Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med 139:642\u2013648","journal-title":"Ann Intern Med"},{"key":"1099_CR57","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1210\/jc.2007-0167","volume":"92","author":"S Radovick","year":"2007","unstructured":"Radovick S, DiVall S (2007) Approach to the growth hormone-deficient child during transition to adulthood. J Clin Endocrinol Metab 92:1195\u20131200","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/cen.12691","volume":"83","author":"IM Holdaway","year":"2015","unstructured":"Holdaway IM, Hunt P, Manning P, Cutfield W, Gamble G, Ninow N et al (2015) Three-year experience with access to nationally funded growth hormone (GH) replacement for GH-deficient adults. Clin Endocrinol (Oxf) 83:85\u201390","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1099_CR59","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/0026-0495(95)90004-7","volume":"44","author":"JO Johansson","year":"1995","unstructured":"Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA (1995) Growth hormone-deficient adults are insulin-resistant. Metabolism 44:1126\u20131129","journal-title":"Metabolism"},{"key":"1099_CR60","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3389\/fendo.2019.00534","volume":"10","author":"AR Castillo","year":"2019","unstructured":"Castillo AR, de Souza AL, Alegre SM, Atala YB, Zantut-Wittmann DE, Garmes HM (2019) Insulin sensitivity is not decreased in adult patients with hypopituitarism without growth hormone replacement. Front Endocrinol (Lausanne). 10:534","journal-title":"Front Endocrinol (Lausanne)."},{"key":"1099_CR61","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s40618-018-0860-x","volume":"41","author":"V Rochira","year":"2018","unstructured":"Rochira V, Mossetto G, Jia N, Cannavo S, Beck-Peccoz P, Aimaretti G et al (2018) Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS). J Endocrinol Investig 41:1259\u20131266","journal-title":"J Endocrinol Investig"},{"key":"1099_CR62","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/cen.13256","volume":"86","author":"MM Weber","year":"2017","unstructured":"Weber MM, Biller BM, Pedersen BT, Pournara E, Christiansen JS, H\u00f6ybye C (2017) The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real-life data from the NordiNet. Clin Endocrinol (Oxf) 86:192\u2013198","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1099_CR63","doi-asserted-by":"publisher","first-page":"E1862","DOI":"10.1210\/jc.2014-1532","volume":"99","author":"KC Yuen","year":"2014","unstructured":"Yuen KC, Roberts CT, Frystyk J, Rooney WD, Pollaro JR, Klopfenstein BJ et al (2014) Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency. J Clin Endocrinol Metab 99:E1862\u2013E1869","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR64","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1210\/jc.2014-2132","volume":"99","author":"E Gomes-Santos","year":"2014","unstructured":"Gomes-Santos E, Salvatori R, Ferr\u00e3o TO, Oliveira CR, Diniz RD, Santana JA et al (2014) Increased visceral adiposity and cortisol to cortisone ratio in adults with congenital lifetime isolated GH deficiency. J Clin Endocrinol Metab 99:3285\u20133289","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR65","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12020-016-1076-5","volume":"56","author":"A Ciresi","year":"2017","unstructured":"Ciresi A, Radellini S, Guarnotta V, Giordano C (2017) The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency. Endocrine 56:579\u2013588","journal-title":"Endocrine"},{"key":"1099_CR66","doi-asserted-by":"publisher","first-page":"e0177175","DOI":"10.1371\/journal.pone.0177175","volume":"12","author":"MG Swainson","year":"2017","unstructured":"Swainson MG, Batterham AM, Tsakirides C, Rutherford ZH, Hind K (2017) Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables. PLoS ONE 12:e0177175","journal-title":"PLoS ONE"},{"key":"1099_CR67","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12020-018-1763-5","volume":"63","author":"AL Andrade-Guimar\u00e3es","year":"2019","unstructured":"Andrade-Guimar\u00e3es AL, Aguiar-Oliveira MH, Salvatori R, Carvalho VO, Alvim-Pereira F, Daniel CRA et al (2019) Adult individuals with congenital, untreated, severe isolated growth hormone deficiency have satisfactory muscular function. Endocrine 63:112\u2013119","journal-title":"Endocrine"},{"key":"1099_CR68","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1210\/jc.2008-1538","volume":"94","author":"G G\u00f6therstr\u00f6m","year":"2009","unstructured":"G\u00f6therstr\u00f6m G, Elbornsson M, Stibrant-Sunnerhagen K, Bengtsson BA, Johannsson G, Svensson J (2009) Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults. J Clin Endocrinol Metab 94:809\u2013816","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR69","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1210\/jc.2012-2006","volume":"97","author":"H Filipsson Nystr\u00f6m","year":"2012","unstructured":"Filipsson Nystr\u00f6m H, Barbosa EJ, Nilsson AG, Norrman LL, Ragnarsson O, Johannsson G (2012) Discontinuing long-term GH replacement therapy\u2013a randomized, placebo-controlled crossover trial in adult GH deficiency. J Clin Endocrinol Metab 97:3185\u20133195","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR70","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11102-020-01031-5","volume":"23","author":"X He","year":"2020","unstructured":"He X, Barkan AL (2020) Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature. Pituitary 23:294\u2013306","journal-title":"Pituitary"},{"key":"1099_CR71","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1210\/jc.2006-0524","volume":"91","author":"H Filipsson","year":"2006","unstructured":"Filipsson H, Monson JP, Koltowska-H\u00e4ggstr\u00f6m M, Mattsson A, Johannsson G (2006) The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91:3954\u20133961","journal-title":"J Clin Endocrinol Metab"},{"key":"1099_CR72","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3389\/fendo.2018.00434","volume":"9","author":"C Graziadio","year":"2018","unstructured":"Graziadio C, Hasenmajer V, Venneri MA, Gianfrilli D, Isidori AM, Sbardella E (2018) Glycometabolic alterations in secondary adrenal insufficiency: does replacement therapy play a role? Front Endocrinol (Lausanne) 9:434","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1099_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000485997","volume":"49","author":"D Milji\u0107","year":"2018","unstructured":"Milji\u0107 D, Popovic V (2018) Metabolic syndrome in hypopituitarism. Front Horm Res 49:1\u201319","journal-title":"Front Horm Res"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01099-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-020-01099-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01099-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T11:33:20Z","timestamp":1650540800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-020-01099-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,24]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1099"],"URL":"https:\/\/doi.org\/10.1007\/s11102-020-01099-z","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,24]]},"assertion":[{"value":"17 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no potential conflict of interest in relation to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the medical ethics committee of the Universidade de S\u00e3o Paulo<b>.<\/b> The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all study subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}